Cargando…
‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation
BACKGROUND: Oncology patients have tremendous symptom burden both physically and emotionally. Palliative care (PC) improves quality of life and prevents suffering. Advance care planning (ACP) empowers patients to articulate goals of their care. New guidelines call for palliative care to be provided...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558017/ https://www.ncbi.nlm.nih.gov/pubmed/37808072 http://dx.doi.org/10.6004/jadpro.2023.14.6.3 |
_version_ | 1785117195490033664 |
---|---|
author | Davis, Jessica Tamar |
author_facet | Davis, Jessica Tamar |
author_sort | Davis, Jessica Tamar |
collection | PubMed |
description | BACKGROUND: Oncology patients have tremendous symptom burden both physically and emotionally. Palliative care (PC) improves quality of life and prevents suffering. Advance care planning (ACP) empowers patients to articulate goals of their care. New guidelines call for palliative care to be provided and chemotherapy avoided the last 2 weeks of life. The American Society of Clinical Oncology (ASCO) recommends integrating palliative care within the oncology setting to achieve these outcomes. However, the best mode to provide this care remains unclear. A nurse practitioner/physician assistant (NP/PA)-based model from within the oncology clinic is a potential option. METHODS: A program evaluation was done to determine the effectiveness of the “My Choices, My Wishes” NP/PA-led program. RESULTS: From 2012 to 2018, the number of patients receiving PC/ACP visits increased from 2.6% to 19.4%. The percentage of patients receiving chemotherapy in the last 14 days of life decreased from 12.5% to 7.14%. The number of advance care directives completed increased from 17.5% to 37.5%. CONCLUSION: This program was an effective way to provide PC/ACP for oncology patients. We still need to understand why patients pursue chemotherapy at the end of life. It is necessary to improve our communication techniques with patients and families in order to guarantee high-quality, high-value care. |
format | Online Article Text |
id | pubmed-10558017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Harborside Press LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-105580172023-10-07 ‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation Davis, Jessica Tamar J Adv Pract Oncol Research & Scholarship BACKGROUND: Oncology patients have tremendous symptom burden both physically and emotionally. Palliative care (PC) improves quality of life and prevents suffering. Advance care planning (ACP) empowers patients to articulate goals of their care. New guidelines call for palliative care to be provided and chemotherapy avoided the last 2 weeks of life. The American Society of Clinical Oncology (ASCO) recommends integrating palliative care within the oncology setting to achieve these outcomes. However, the best mode to provide this care remains unclear. A nurse practitioner/physician assistant (NP/PA)-based model from within the oncology clinic is a potential option. METHODS: A program evaluation was done to determine the effectiveness of the “My Choices, My Wishes” NP/PA-led program. RESULTS: From 2012 to 2018, the number of patients receiving PC/ACP visits increased from 2.6% to 19.4%. The percentage of patients receiving chemotherapy in the last 14 days of life decreased from 12.5% to 7.14%. The number of advance care directives completed increased from 17.5% to 37.5%. CONCLUSION: This program was an effective way to provide PC/ACP for oncology patients. We still need to understand why patients pursue chemotherapy at the end of life. It is necessary to improve our communication techniques with patients and families in order to guarantee high-quality, high-value care. Harborside Press LLC 2023-09 2023-09-01 /pmc/articles/PMC10558017/ /pubmed/37808072 http://dx.doi.org/10.6004/jadpro.2023.14.6.3 Text en © 2023 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research & Scholarship Davis, Jessica Tamar ‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation |
title | ‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation |
title_full | ‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation |
title_fullStr | ‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation |
title_full_unstemmed | ‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation |
title_short | ‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation |
title_sort | ‘my choices, my wishes' program and its effect on chemotherapy at the end of life and advance care directive documentation |
topic | Research & Scholarship |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558017/ https://www.ncbi.nlm.nih.gov/pubmed/37808072 http://dx.doi.org/10.6004/jadpro.2023.14.6.3 |
work_keys_str_mv | AT davisjessicatamar mychoicesmywishesprogramanditseffectonchemotherapyattheendoflifeandadvancecaredirectivedocumentation |